Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $16,116 - $19,347
-1,430 Reduced 33.06%
2,896 $34,000
Q4 2023

Feb 07, 2024

SELL
$8.77 - $10.85 $11,558 - $14,300
-1,318 Reduced 23.35%
4,326 $46,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $34,610 - $40,962
-3,609 Reduced 39.0%
5,644 $55,000
Q2 2023

Jul 24, 2023

SELL
$9.02 - $10.29 $11,843 - $13,510
-1,313 Reduced 12.43%
9,253 $92,000
Q1 2023

May 09, 2023

BUY
$9.2 - $12.26 $4,811 - $6,411
523 Added 5.21%
10,566 $101,000
Q4 2022

May 09, 2023

BUY
$8.72 - $11.56 $87,574 - $116,097
10,043 New
10,043 $111,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.